Prevalence and treatment of metabolic syndrome in adolescents with type 2 diabetes

Annals of Pharmacotherapy

Volumn 40, Issue 9, 2006, Pages 1517-1521

  Sanders, Brittany Harris ^a,b   Lubsch, Lisa M ^c   West, Donna S ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Walgreens   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

Adherence; Adolescents; Diabetes; Metabolic syndrome

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; INSULIN; METFORMIN; SULFONYLUREA;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COMPLIANCE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTILIPEMIC AGENTS; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METABOLIC SYNDROME X; PATIENT COMPLIANCE; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 33748294316     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H130     Document Type: Article

References (24)

1. American Diabetes Association. Type 2 diabetes in children and adolescents (Consensus Statement). Diabetes Care 2000;23:381-9.
2. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000;136:664-72.
3. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 1998;101:497-504.
4. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States. 1999-2004. JAMA 2006;295:1549-55.
5. Williams CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood: statement for health professionals from the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young. Circulation 2002;106:143-60.
6. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
8. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52:1210-4.
9. Must A, Jacques PF, Dallal GE, et al. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992;327:1350-5.
10. Berenson GS. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease: the Bogalusa heart study. Am J Cardiol 2002;90:3L-7L.
11. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11 2002; 246:1-190.
12. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-75.
13. de Ferranti SD, Gauvreau K, Ludwig DS, et al. Prevalence of the metabolic syndrome in American adolescents. Findings from the third national health and nutrition examination survey. Circulation 2004;110:2494-7.
14. Duncan GE, Li SM, Zhou X. Prevalence and trends of a metabolic syndrome phenotype among US adolescents, 1999-2000. Diabetes Care 2004;27:2438-43.
15. Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syndrome phenotype in adolescents. Findings from the third national health and nutrition examination survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-7.
16. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74.
17. American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes (Consensus Statement). Diabetes Care 2003;26:2194-7.
18. American Diabetes Association. Standards of medical care in diabetes (Position Statement). Diabetes Care 2005;28(suppl):S4-36.
19. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50.
20. Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 diabetes. Diabetes Care 2002;25:89-94.
21. National Institute of Diabetes and Digestive and Kidney Diseases. Treatment options for type 2 diabetes in adolescents and youth (TODAY). www.todaystudy.org/medpl.cgi (accessed 2005 Mar30).
22. Grant RW, Cagliero E, Murphy-Sheehy P, et al. Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med 2002;112:603-9.
23. Hillier TA, Pedula KL. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 2003;26:2999-3005.
24. UKPDS Group. Intensive blood glucose control with sulfphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.